# Hymovis™ Versus Placebo in Knee Osteoarthritis

> **NCT01372475** · PHASE3 · COMPLETED · sponsor: **Fidia Farmaceutici s.p.a.** · enrollment: 800 (actual)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **DEVICE:** Hymovis Intra-articular Injection
- **PROCEDURE:** Phosphate Buffered Saline Injection

## Key facts

- **NCT ID:** NCT01372475
- **Lead sponsor:** Fidia Farmaceutici s.p.a.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2012-11
- **Final completion:** 2013-02
- **Target enrollment:** 800 (ACTUAL)
- **Last updated:** 2014-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01372475

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01372475, "Hymovis™ Versus Placebo in Knee Osteoarthritis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01372475. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*